Biomedical Engineering Reference
In-Depth Information
33. Dufes, C.; Uchegbu, I.; Schatzlein, A. Dendrimers in Gene Delivery.
Adv. Drug Deliv. Rev.
2005,
57,
2177.
34. Allen, T. M.; Mumbengegwi, D. R.; Charrois, G. J. Anti-CD19-targeted Liposomal Doxo-
rubicin Improves the Therapeutic Efficacy in Murine B-cell Lymphoma and Ameliorates
the Toxicity of Liposomes with Varying Drug Release Rates.
Clin. Cancer Res.
2005,
11,
3567-3573.
35. Barreiro, A.; Rurali, R.; Harnandez, E. R.; Moser, J.; Pichler, T. F.; L., et al. Subnanometer
Motion of Cargos Driven by Thermal Gradients Along Carbon Nanotubes.
Science
2008,
320,
775-778.
36. Bertholon, I.; Ponchel, G.; Labarre, D.; Couvreur, P.; Vauthier, C. Bioadhesive Properties of
Poly(alkylcyanoacrylate) Nanoparticles Coated with Polysaccharide.
J. Nanosci. Nanotechnol.
2006,
6,
3102-3109.
37. Beyerle, A.; Merkel, O.; Stoeger, T.; Kissel, T. PEGylation Affects Cytotoxicity and Cell-
compatibility of Poly(ethylene imine) for Lung Application: Structure Function Relation-
ships.
Toxicol. Appl. Pharmacol.
2010,
242,
146-154.
38. Blum, J. L.; Savin, M. A.; Edelman, G.; Pippen, J. E.; Robert, N. J.; geister, B. V.; Kirby, R.
L.; Clawson, A.; O'shaughnessy, J. A. Phase II Study of Weekly Albumin-bound Paclitaxel for
Patients with Metastatic Breast Cancer Heavily Pretreated with Taxanes.
Clin. Breast Cancer
2007,
7,
850-856.
39. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in Cancer Therapy and Diagnosis.
Adv.
Drug Del. Rev.
2002,
54,
631-651.
40. Calvo, P.; Remuñan-López, C.; Vila-Jato, J. L.; Alonso, M. J. Chitosan and Chitosan/Ethylene
Oxide-propylene Oxide Block copolymer Nanoparticles as Novel Carriers for Proteins and
Vaccines.
Pharm. Res.
1997,
14,
1431-1436.
41. Chen, Y.; McCulloch, R. K.; Gray, B. N. Synthesis of Albumin-Dextran Sulfate Microspheres
Possessing Favourable Loading and Release Characteristics for the Anticancer Drug Doxoru-
bicin.
J Controlled Release
1994,
31,
49-54.
42. Couvreur, P.; Barratt, G.; Fattal, E.; Legrand, P.; Vauthier, C. Nanocapsule Technology:
A Review.
Crit. Rev. Ther. Drug Carrier Syst.
2002,
19,
99134.
43. Dang, J. M.; Leong, K. W. Natural Polymers for Gene Delivery and Tissue Engineering.
Adv.
Drug Deliv. Rev.
2006,
58,
487-499.
44. Kreyling, W. G.; Möller, W.; Semmler-Behnke, M.; Oberdörster, G. In
Particle Toxicology
;
Born, D. K., Ed.; CRC Press: Boca Raton, 2007.
45. Linhardt, R. J. In
Controlled Release of Drugs
; Rosoff, M., Ed.; VCH Publishers: New York,
1989; pp 53-95.
46. Muller, R. H.; Mader, K.; Gohla, S. Solid Lipid Nanoparticles (SLN) for controlled Drug
Delivery ± A Review of the State of the Art.
Eur. J. Pharm. Biopharm.
2000,
50,
161-177.
47. Panyam, J.; Labhasetwar, V. Biodegradable Nanoparticles for Drug and Gene Delivery to
Cells and Tissue.
Adv. Drug Deliv. Rev.
2003,
12,
329-347.
48. Redhead, H. M.; Davis, S. S.; Illum, L. Drug Delivery in Poly(lactide-co-glycolide) Nanopar-
ticles Surface Modified with Poloxamer 407 and Poloxamine 908: In vitro Characterisation
and In vivo Evaluation.
J. Controlled Release
2001,
70,
353-363.
49. Yang, L.; Cao, Z.; Sajja, H.; Mao, H.; Wang, L.; Geng, H.; Xu, H.; Jiang, T.; Wood, W.; Nie,
S.; Wang, A. Development of Receptor Targeted Iron Oxide Nanoparticles for Efficient Drug
Delivery and Tumor imaging.
J. Biomed. Nanotech.
2008,
4,
1-11.
50. Yang, L.; Peng, X.; Wang, Y.; Wang, X.; Cao, Z.; Ni, C.; Karna, P.; Zhang, X.; Wood, W.; Gao,
X.; Nie, S.; Mao, H. Receptor-targeted Nanoparticles for In vivo Imaging of Breast Cancer.
Clin. Cancer Res.
2009,
15,
4722-4732.
